Analysts expect Summit Therapeutics Inc. to report revenue of 68,417.44 for Q3 26, against a range of 64,330.93 to 72,503.95. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 54,760.73 | 0.00 | 72,503.95 | 4.03 M | 11.13 M | 19.41 M | 12.89 M | 15.74 M | 135.49 M | 169.04 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 50,156.13 | 0.00 | 64,330.93 | 3.35 M | 9.77 M | 17.65 M | 11.01 M | 13.33 M | 117.52 M | 138.51 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 52,458.43 | 0.00 | 68,417.44 | 3.69 M | 10.45 M | 18.53 M | 11.95 M | 14.53 M | 126.50 M | 153.77 M |
Analysts expect Summit Therapeutics Inc. to report earnings per share of -0.28 for Q3 26, against a range of -0.31 to -0.25. The most recent reported quarter, Q2 26, came in at -0.28, a 3.4% beat against the -0.29 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.08 | -0.08 | -0.09 | -0.76 | -0.31 | -0.29 | -0.24 | -0.28 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.07 | -0.08 | -0.08 | -0.08 | -0.08 | -0.08 | -0.24 | -0.26 | -0.25 | -0.35 | -0.26 | -0.26 | -0.23 | -0.32 | -0.20 | -0.19 | ||||||||||
| Low Estimate | -0.07 | -0.10 | -0.08 | -0.10 | -0.08 | -0.08 | -0.28 | -0.32 | -0.31 | -0.39 | -0.30 | -0.32 | -0.25 | -0.38 | -0.24 | -0.23 | ||||||||||
| Consensus Estimate | -0.07 | -0.09 | -0.08 | -0.09 | -0.08 | -0.08 | -0.26 | -0.29 | -0.28 | -0.37 | -0.28 | -0.29 | -0.24 | -0.35 | -0.22 | -0.21 |
Pull Wall Street consensus for Summit Therapeutics Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=SMMT&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "SMMT", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=SMMT&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();